Jazz Pharmaceuticals JAZZ Change in Inventories
Change in Inventories at other companies
Other financials
Where this comes from
Reported directly by Jazz Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInInventories.
The official record: Jazz Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Jazz Pharmaceuticals's change in inventories.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Jazz Pharmaceuticals's change in inventories?
- Jazz Pharmaceuticals (JAZZ) reported change in inventories of $77.8M in Q1 2026.
- How has Jazz Pharmaceuticals's change in inventories changed year-over-year?
- Jazz Pharmaceuticals's change in inventories increased by 118.5% year-over-year, from $35.6M to $77.8M.
- What is the long-term trend for Jazz Pharmaceuticals's change in inventories?
- Over 4 years (2021 to 2025), Jazz Pharmaceuticals's change in inventories has grown at a 17.7% compound annual growth rate (CAGR), from $48.86M to $93.76M.
- What does change in inventories mean?
- The change in the value of goods held in inventory.
- How do you interpret change in inventories?
- An increase in inventory consumes cash, while a decrease releases cash tied up in stock.
- How does change in inventories compare across companies?
- Highly dependent on industry; biopharma companies often hold significant inventory for long-cycle drug production.